Law360, New York (July 11, 2004, 12:00 AM ET) -- In a lawsuit that reaffirms a key principle in New Zealand’s patent policy, Pfizer has lost an appeal seeking a reversal of a High Court decision that the company could not patent a method of treating psychotic disorders using a new compound.
The unanimous decision by the Court of Appeals affirmed the principle that methods of treating disease or illness in humans cannot be patented in New Zealand. While the compound itself could be legally protected, the way it was used could not, according to the...
New Zealand Reaffirms Ban On "Methods" Patents
To view the full article, take a free trial now.
